This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $162,000.00 to the University of South Carolina to develop and implement an equity-driven research training program. The program aims to build capacity and expertise in integrating community engagement, health communication, and implementation science research to advance the science on Alzheimer's disease and related dementias (ADRD) disparities and outcomes, particularly among...
This federal Project Grant award of $1,382,260, provided by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) program, supports research to develop a methodological framework for examining individual and group-level dynamics associated with information-seeking and care-seeking behaviors related to risk reduction and early detection of Alzheimer's disease and related dementias (ADRD). The research will employ a mixed-methods approach utilizing theories from human...
This $1,010,230 Project Grant award, funded by the National Institute on Aging (CFDA 93.866 Aging Research), supports research to evaluate the feasibility and effectiveness of a culturally-adapted mindfulness-based program (MBP) for Latinx older adults at risk of developing Alzheimer's disease (AD). The Washington University is leading this R61 research project, which aims to address disparities in AD burden among Latinx communities through a new MBP intervention tailored to their specific...
This Project Grant award, funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), aims to conduct a 20-year longitudinal study examining psychosocial risk and protective factors for cognitive functioning among middle-aged and older Black Americans. The $2,118,030 award will support the re-interview of approximately 2,600 participants from the nationally representative National Survey of American Life (NSAL) sample, with enhanced data collection including...
This $767,193 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to identify undiagnosed Alzheimer's disease (AD) in underserved Hispanic/Latino and African American populations. The key products and services to be delivered under this award include: Identifying disease trajectories associated with AD to help predict undiagnosed cases, while accounting for underdiagnosis bias in the target populations (Aims 1-2). Integrating...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), has awarded a $299,553 Project Grant to Pilltrax Systems LLC to develop an enhanced medication management service for providers caring for African American and Latino older adults at risk of Alzheimer's disease and related dementias (ADRD). The proposed solution will comprise an electronic pill dispenser that sends medication adherence notifications, an adherence assessment tool, and a provider...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), provides $2,557,260 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the early transition to Alzheimer's disease and related dementias (ADRD) among Black and White adults in their 60s. The 5-year study aims to investigate the life course predictors and underlying mechanistic pathways leading to the early manifestation of ADRD, with a...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $499,796 to Clear Session, Inc. to develop an innovative digital visualization tool to improve communication between clinicians, Latino Alzheimer's disease and related dementias (ADRD) patients, and their caregivers. The tool is designed to be linguistically and culturally tailored to break down complex medical information in a clear and comprehensible way, thereby enhancing healthcare...
This Project Grant award of $1,550,462 from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) program, supports a 5-year multidisciplinary study investigating Alzheimer's disease (AD) risk factors in older Black/African American adults living with HIV. The study aims to examine the impacts of the APOE E4 gene variant, HIV disease, and their potential interaction on brain function in this vulnerable population, who may face a greater risk of developing Alzheimer's...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $235,795 to generate socially- and culturally-aligned approaches for engaging Black communities in Southern California in brain health research and build a Black aging cohort. The key activities include: 1) identifying and engaging stakeholders in Los Angeles and Orange counties to...